These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 8129813)

  • 21. Depression: the relevance of the time factor.
    Pinder RM
    J Clin Psychiatry; 2001; 62 Suppl 15():5-7. PubMed ID: 11444764
    [No Abstract]   [Full Text] [Related]  

  • 22. The use of pindolol to potentiate antidepressant medication.
    Blier P; Bergeron R
    J Clin Psychiatry; 1998; 59 Suppl 5():16-23; discussion 24-5. PubMed ID: 9635544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frontal 5-HT2A receptors studied in depressive patients during chronic treatment by selective serotonin reuptake inhibitors.
    Massou JM; Trichard C; Attar-Levy D; Feline A; Corruble E; Beaufils B; Martinot JL
    Psychopharmacology (Berl); 1997 Sep; 133(1):99-101. PubMed ID: 9335087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple serotonergic paths to antidepressant efficacy.
    Lutz PE
    J Neurophysiol; 2013 May; 109(9):2245-9. PubMed ID: 23343901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is serotonin an upper or a downer? The evolution of the serotonergic system and its role in depression and the antidepressant response.
    Andrews PW; Bharwani A; Lee KR; Fox M; Thomson JA
    Neurosci Biobehav Rev; 2015 Apr; 51():164-88. PubMed ID: 25625874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotonergic mechanisms and the new antidepressants.
    Stahl SM
    Psychol Med; 1993 May; 23(2):281-5. PubMed ID: 8332642
    [No Abstract]   [Full Text] [Related]  

  • 27. Olanzapine augments the effect of selective serotonin reuptake inhibitors by suppressing GABAergic inhibition via antagonism of 5-HT₆ receptors in the dorsal raphe nucleus.
    Asaoka N; Nagayasu K; Nishitani N; Yamashiro M; Shirakawa H; Nakagawa T; Kaneko S
    Neuropharmacology; 2015 Aug; 95():261-8. PubMed ID: 25863120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonergic synergism: the risks and benefits of combining the selective serotonin reuptake inhibitors with other serotonergic drugs.
    DeBattista C; Sofuoglu M; Schatzberg AF
    Biol Psychiatry; 1998 Sep; 44(5):341-7. PubMed ID: 9755356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The neuropharmacology of serotonin and noradrenaline in depression.
    Nutt DJ
    Int Clin Psychopharmacol; 2002 Jun; 17 Suppl 1():S1-12. PubMed ID: 12369606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Augmentation of SSRI effects on serotonin by 5-HT2C antagonists: mechanistic studies.
    Cremers TI; Rea K; Bosker FJ; Wikström HV; Hogg S; Mørk A; Westerink BH
    Neuropsychopharmacology; 2007 Jul; 32(7):1550-7. PubMed ID: 17203017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of action of trazodone: a multifunctional drug.
    Stahl SM
    CNS Spectr; 2009 Oct; 14(10):536-46. PubMed ID: 20095366
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacology of antidepressants.
    Frazer A
    J Clin Psychopharmacol; 1997 Apr; 17 Suppl 1():2S-18S. PubMed ID: 9090573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment strategy of refractory depression and its presynaptic mechanism of action].
    Inoue T; Kitaichi Y; Koyama T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Feb; 23(1):11-20. PubMed ID: 12690637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Melatoninergic antidepressant valdoxan].
    Arushanian ÉB
    Eksp Klin Farmakol; 2011; 74(7):41-5. PubMed ID: 21894769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential mechanisms of action of atypical antipsychotic medications in treatment-resistant depression and anxiety.
    Blier P; Szabo ST
    J Clin Psychiatry; 2005; 66 Suppl 8():30-40. PubMed ID: 16336034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of 5-HT1A receptors in the antidepressant-like effect of adenosine in the mouse forced swimming test.
    Kaster MP; Santos AR; Rodrigues AL
    Brain Res Bull; 2005 Sep; 67(1-2):53-61. PubMed ID: 16140163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive value of pharmacological activity for the relative efficacy of antidepressant drugs. Meta-regression analysis.
    Freemantle N; Anderson IM; Young P
    Br J Psychiatry; 2000 Oct; 177():292-302. PubMed ID: 11116769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prescribing update: why choose duloxetine for depression?
    Tobin ML
    Issues Ment Health Nurs; 2007 Jan; 28(1):117-20. PubMed ID: 17130011
    [No Abstract]   [Full Text] [Related]  

  • 39. Beyond the serotonin reuptake inhibitors: rationales for the development of new serotonergic agents.
    Dubovsky SL
    J Clin Psychiatry; 1994 Feb; 55 Suppl():34-44. PubMed ID: 8077173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response.
    Blier P; Bergeron R; de Montigny C
    Neuropsychopharmacology; 1997 May; 16(5):333-8. PubMed ID: 9109104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.